Industry payments and brand-name tyrosine kinase inhibitor use amid generic entry

被引：1
|
作者：
Sun, Q. Wilton [1 ]
Forman, Howard P. [2 ,3 ,4 ]
Ross, Joseph S. [3 ,5 ]
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Yale Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA
[3] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA
[4] Yale Sch Management, New Haven, CT USA
[5] Yale Sch Med, Dept Internal Med, Sect Gen Internal Med, 333 Cedar St, New Haven, CT 06510 USA
来源：
CLINICAL TRIALS | 2024年 / 21卷 / 02期
关键词：
D O I：
10.1177/17407745231207971
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：257 / 259
页数：3
相关论文
共 50 条
  • [41] Generic versus brand-name cardiovascular drugs: a remarkable update
    Flacco, Maria Elena
    Fragassi, Giorgia
    Manzoli, Lamberto
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2015, 12 (04)
  • [42] Converting patients from brand-name clozapine to generic clozapine
    Sajbel, TA
    Carter, GW
    Wiley, RB
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (03) : 281 - 284
  • [43] Investigation of Bioequivalence Between Brand-name and Generic Irinotecan Products
    Saito, Ken-Ichi
    Inoue, Yutaka
    Ikegami, Yoji
    Nanbo, Izumi
    Onozuka, Mari
    Sano, Kazumi
    Yoshida, Hisahiro
    Sakamoto, Toshihiro
    Tatebayashi, Emi
    Fujita, Ken-Ichi
    Sasaki, Yasutsuna
    Kitazawa, Takaki
    ANTICANCER RESEARCH, 2016, 36 (11) : 5957 - 5963
  • [44] Generic versus brand-name drugs used in cardiovascular diseases
    Lamberto Manzoli
    Maria Elena Flacco
    Stefania Boccia
    Elvira D’Andrea
    Nikola Panic
    Carolina Marzuillo
    Roberta Siliquini
    Walter Ricciardi
    Paolo Villari
    John P. A. Ioannidis
    European Journal of Epidemiology, 2016, 31 : 351 - 368
  • [45] Continuing trends in US brand-name and generic drug competition
    Grabowski, Henry
    Long, Genia
    Mortimer, Richard
    Bilginsoy, Mehmet
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 908 - 917
  • [46] Response of Behcet's syndrome to brand-name but not generic tetracycline
    Cohen, JB
    Bergstresser, PR
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1997, 22 (03) : 159 - 160
  • [47] Differences in fluidity and viscosity of brand-name and generic injectable ointment
    Ishimura, Atsushi
    Ogawa, Chiaki
    Yatabe, Megumi
    Tani, Kentaro
    Inoue, Motoki
    DRUG DISCOVERIES AND THERAPEUTICS, 2024, 18 (04): : 265 - 268
  • [48] GENERIC AND ALTERNATIVE BRAND-NAME PHARMACEUTICAL EQUIVALENTS - SELECT WITH CAUTION
    HENDELES, L
    HOCHHAUS, G
    KAZEROUNIAN, S
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (02): : 323 - 329
  • [49] Plan Designs That Encourage the Use of Generic Drugs Over Brand-Name Drugs: An Analysis of a Free Generic Benefit
    Rodin, Holly A.
    Heaton, Alan H.
    Wilson, Amy R.
    Garrett, Nancy A.
    Plocher, David W.
    AMERICAN JOURNAL OF MANAGED CARE, 2009, 15 (12): : 881 - 888
  • [50] Information provided by generic and brand-name pharmaceutical manufacturers in response to a request
    Fernandez-Llimos, Fernando
    Gomez, Isabel Vazquez
    PHARMACY WORLD & SCIENCE, 2007, 29 (06): : 683 - 687
12345